Parker-Hannifin Corporation PH
Composite 54/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 22/100 — a strong mark against it.
Quality ranks 74/100 — a moderate point in its favour. Balance-sheet strength ranks 64/100 — a moderate point in its favour. Momentum ranks 58/100 — a slight point in its favour.
Valuation ranks 22/100 — a strong mark against it. Income ranks 42/100 — a slight mark against it.
What the company does Parker-Hannifin Corporation designs and manufactures motion and control technologies and systems across aerospace, industrial, transportation, energy, and HVAC markets. Its segments include Diversified Industrial and Aerospace Systems, supplying components like seals, valves, pumps, and filtration solutions.
Key financials The company reports strong profitability metrics: ROE 25.1%, ROA 9.8%, ROCE 20.0%, and net margins of 17.0%. Revenue and EPS growth stand at 8.3% and 5.0%, respectively. Financial health is solid with a Piotroski F-Score of 8/9, Altman Z of 7.27, and interest coverage of 12.38x.
Stock health Momentum is mixed: +14.07% over 3 months, -3.29% over 6 months, and +26.73% over 12 months. The stock is -13.27% below its 52-week high, with an RSI(14) of 36.40 indicating oversold conditions.
Price vs fair value PH trades at a discount of 21.90% versus the analyst mean target of 1160.95. - Discount reflects high valuation ratios: P/E 34.89 (fwd 28.82), PEG 3.39, EV/EBITDA 22.96 (Valuation 22.4/100). - Quality scores are strong (73.5/100), but growth (50.2/100) and income (42.2/100) lag. - Recent headlines highlight cash flow strength but do not address valuation concerns (Dividend Stocks article).
Looking forward Forward P/E of 28.82 and PEG of 1.37 suggest growth is priced at a premium. Analysts may weigh margin stability and aerospace demand against current multiples. Momentum and oversold RSI could attract interest, but high valuation metrics remain a headwind.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.